首页> 美国卫生研究院文献>International Journal of Retina and Vitreous >Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis

【2h】

Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis

机译：三联疗法和玉米黄质治疗新生血管性年龄相关性黄斑变性的介入比较研究和成本效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundReports of triple combination therapy for neovascular age-related macular degeneration (AMD) suggest a benefit, as do reports for zeaxanthin. An interventional comparative study was thus undertaken to evaluate the efficacy of triple combination therapy with and without zeaxanthin, as well as the economic viability of the therapies.

机译：背景技术针对新生血管性年龄相关性黄斑变性（AMD）的三联疗法的报告显示出一种益处，而玉米黄质的报道也是如此。因此，进行了一项干预性比较研究，以评估含或不含玉米黄质的三联疗法的疗效，以及该疗法的经济可行性。

著录项

期刊名称 International Journal of Retina and Vitreous
作者
R. Joseph Olk; Enrique Peralta; Dennis L. Gierhart; Gary C. Brown; Melissa M. Brown;
展开▼
作者单位

展开▼
年(卷),期 2015(1),-1
年度 2015
页码 22
总页数 11
原文格式 PDF
正文语种
中图分类眼科学 ;
关键词
Zeaxanthin Macular pigment Combination therapy Neovascular age-related macular neovascularization Cost-effective;

机译：玉米黄质;黄斑色素;联合疗法;与年龄有关的新生血管性黄斑新生血管;具有成本效益;

相似文献

外文文献
中文文献
专利

1. Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration [J] . Elman Michael J., Brown David M., Kaiser Peter K., Investigative ophthalmology & visual science . 2018 ,第9期

机译：与Ranibizimab双药草的治疗幼鱼乳蛋白单疗法与Ranibizimab与ranibizimab与Ranibizimab单疗法相比，与Ranibizimab的单一治疗与Ranibizimab双胍溶解的临床研究与Ranibizimab Ophthalmic溶液相比，与Ranibizimab的治疗中的治疗中的幼苗单一治疗相比，临床研究与Ranibizimizumab相比。退化
2. Clinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular DegenerationClinical Study of Squalamine Lactate Ophthalmic Solution 0.2% in Combination with Ranibizumab Compared to Ranibizimab Monotherapy in Treatment Naive Neovascular Age-Related Macular Degeneration [J] . Elman Michael J., Brown David M., Kaiser Peter K., Investigative ophthalmology & visual science . 2018 ,第9期

机译：与Ranibizimab双药草的治疗幼鱼乳蛋白单疗法与Ranibizimab与ranibizimab与Ranibizimab单疗法相比，与Ranibizimab的单一治疗与Ranibizimab双胍溶解的临床研究与Ranibizimab Ophthalmic溶液相比，与Ranibizimab的治疗中的治疗中的幼苗单一治疗相比，临床研究与Ranibizimizumab相比。退化
3. A retrospective analysis of triple combination therapy with intravitreal bevacizumab, posterior sub-tenon's triamcinolone acetonide, and low-fluence verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration. [J] . Kovacs KD, Quirk MT, Kinoshita T, Retina . 2011 ,第3期

机译：对新生血管性黄斑变性患者三联联合玻璃体内注射贝伐单抗，后腱下曲安奈德和低通量维替泊芬光动力疗法的回顾性分析。
4. Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration [C] . Leilei Zhang, Jeff Xu, Jiwei Huang, Conference on ophthalmic technologies . 2010

机译：贝伐单抗（Avastin）缀合的微泡用于抗VEGF治疗新生血管性年龄相关性黄斑变性
5. Combined Cell and Gene Therapy towards the Treatment of Age-related Macular Degeneration and Diabetic Retinopathy [D] . Petrou, Sabiha Hacibekiroglu. 2018

机译：细胞和基因联合疗法治疗老年性黄斑变性和糖尿病性视网膜病
6. Comparative Safety of Bevacizumab Ranibizumab and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies [O] . Anna A. Plyukhova, Maria V. Budzinskaya, Kirill M. Starostin, 2020

机译：贝伐单抗雷珠单抗和阿柏西普治疗新血管性年龄相关性黄斑变性（AMD）的比较安全性：直接比较研究的系统评价和网络Meta分析
7. Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis [O] . R. Joseph Olk, Enrique Peralta, Dennis L. Gierhart, 2015

机译：三联疗法和玉米黄质治疗新生血管性年龄相关性黄斑变性的介入比较研究和成本效益分析

Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis

摘要

著录项

相似文献

相关主题

期刊订阅